Live Breaking News & Updates on Oncxerna Therapeutics

Stay updated with breaking news from Oncxerna therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without ....

United States , Yujin Hoshida , Eugenep Frenkel , Paula Calvert , Jay Lohrey , Radhika Kainthla , Chul Ahn , Jakel Hamon , Leticia Khosama , Amitg Singal , Peter Odonnell Jr , Ellen Siglinsky , Adamc Yopp , Heather Kline , Willisc Maddrey , David Hsieh , Zhao Zhu , Syedm Kazmi , Rolf Brekken , Courtney Katz , Mary Claire Maxwell , Research Institute Of Texas , Cancer Center Support Grant , Therapeutic Oncology Research , Simmons Cancer Center , Tissue Regeneration Program ,

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without ....

United States , Paula Calvert , Eugenep Frenkel , Yujin Hoshida , Jay Lohrey , Leticia Khosama , Jakel Hamon , Chul Ahn , Radhika Kainthla , Peter Odonnell Jr , Amitg Singal , Adamc Yopp , Ellen Siglinsky , Heather Kline , David Hsieh , Willisc Maddrey , Mary Claire Maxwell , Courtney Katz , Rolf Brekken , Zhao Zhu , Syedm Kazmi , Hamon Center , Parkland Health , Odonnell School Of Public Health , Clinical Research Manager , Children Medical Center Research Institute ,

7 Biotech Stocks to Buy for Big-Time Gains

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research. ....

Chris Shibutani , Koninklijke Philips , Daiichi Sankyo , Eli Lilly , Merck Co , Us Food Drug Administration , Google Health , Eli Lilly Co , Novo Nordisk , Goldman Sachs , Drug Administration , Portfolio Grader , Radiology Partners , Oncxerna Therapeutics ,

Here's how AI could impact treatments for cancer patients

A case study on OncXerna Therapeutics, which is developing an AI-driven precision medicine platform that will match oncology patients with the best treatment options. ....

United States , Atiya Irvin Mitchell , Laurae Benjamin , Sharpsburg Biohybrid Solutions , Technology Center , Massachusetts Based Oncxerna Therapeutic , Biohybrid Solutions , Oncxerna Therapeutics , Groundtruth Project , Biotech Month ,

Investigation of Ubamatamab With or Without Cemiplimab Continues in Recurrent Ovarian Cancer

The preliminary efficacy, safety, and optimal dose of the MUC16xCD3 bispecific antibody ubamatamab alone or in combination with cemiplimab-rwlc continues to be explored in patients with advanced platinum-resistant ovarian cancer in the phase 2 portion of an ongoing, first-in-human, phase 1/2 study. ....

Oklahoma City , United States , University Of Oklahoma , Verastem Pharmacyclics , Glaxosmithkline Tesaro , Kathleenn Moore , Genentech Roche , Mereo Biopharma , Iovance Biotherapeutics , Daiichi Sankyo Lilly , Bristol Myers Squibb , University Of Oklahoma College Medicine , Oklahoma University Ou Health Stephenson Cancer Center , Novartis Pharmaceuticals United Kingdom Ltd , Phasei Program , Caris Life Sciences , Lilly Foundation , Clinical Research , Oklahoma University , Health Stephenson Cancer Center , Gynecologic Oncology , Oklahoma College , Blueprint Medicines , Clovis Oncology , Hengrui Pharmaceutical , Myriad Genetics ,